Dr. Sadeer Alkindi, MD

Dr. Alkindi practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Alkindi's NPI, 1518308931, was assigned on July 14, 2013. Dr. Alkindi graduated from Weill Cornell Medical College in Qatar in 2013. Dr. Alkindi holds Texas license U2045.

Dr. Alkindi's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Alkindi's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Alkindi is also affiliated with Houston Methodist Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Alkindi to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alkindi practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Alkindi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Alkindi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Alkindi's licenses on file in 2 states: Texas and Ohio.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, cerebrovascular disease, chronic hypertension, heart failure and heart valve disorders among the conditions Dr. Alkindi treats.

CMS data shows 862 Medicare services from Dr. Alkindi across 13 procedure codes in 2024, for 383 Medicare patients. Medicare paid $53,820 for them.

CMS counts 383 Medicare patients who saw Dr. Alkindi in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alkindi's median patient age at 70, with 53% women.

In 2024, Dr. Alkindi wrote 621 Medicare Part D claims for 131 patients. 83% of them were for generic drugs. CMS names the drug for 484 of them, across 18 drugs with 11 or more claims each, at $92,291 in total drug cost. In 2023, CMS named 431 claims across 18 drugs.

Dr. Alkindi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alkindi as offering telehealth.

Dmand AI links Dr. Alkindi to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 111 general payments to Dr. Alkindi from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. HeartFlow, Inc. paid the most, $4,482. It also lists 1 research payment totaling $594 in 2025.

Dmand AI lists 2 awards for Dr. Alkindi, most recently Visconsi Scholar in 2020.

Dr. Alkindi graduated from Weill Cornell Medical College in Qatar in 2013. Dr. Alkindi is a member of ACC.

Dr. Alkindi is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.